Location: Home
  • search
  • go
  • Relate News
  • 6/21/2022China's May Fundraising Indicates Interest in Early-stage Biotech
  • 6/21/2022Xuanzhu Biopharma Out-licenses Greater China Rights of Two Anti-infect...
  • 6/21/2022Innovent and Lilly Jointly Announce Chinese Approval of TYVYT Combo wi...
  • 6/21/2022JPO Issues Bidding Documents for the 7th Round of Volume-Based Procure...
  • 6/21/2022AstraZeneca to Open New Regional Headquarters in Qingdao
  • 6/18/2022Understanding China's Internet Healthcare and Opportunities for Invest...
  • 6/16/2022Pharma Downplays Challenges, Seeing Innovation Instead (Biospace)
  • 6/16/2022May Approvals Spotlight the Rise of Pediatric Drugs under Policy Suppo...
  • 6/16/2022WuXi ATU and Wugen Form Manufacturing Partnership for Novel Cell Cance...
  • 6/15/2022Data Snapshot: Competitive Landscape of Chinese Biosimilars
  • 6/15/2022NMPA Holds Forum to Hear Feedbacks from Pharma MNCs
  • 6/15/2022NHSA Releases the Draft Working Plan and the Application Guide for Adj...
  • 6/14/2022IQVIA: Chinese Retail Pharmacy Sales Down 1.2% in Q1/2022
  • 6/14/2022NHSA Publishes 2021 National Basic Medical Insurance Sector Developmen...
  • 6/14/2022Pharma Giants Turn to Incubators to Tap Chinese Innovation and Hatch S...
  • 6/14/2022FDA's Treatment of China-Developed Drugs Spurs Demands for Multiregion...
  • 6/10/2022Delisting Risk, Souring Relations Are Hurdles for Chinese Biotech Firm...
  • 6/10/2022NHC and SATCM Issue the Rules for Internet Diagnosis and Treatment Reg...
  • 6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...
  • 6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...
  • 6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021
  • 6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031
  • 6/7/2022Fosun Pharma Acquires 60% of Singapore OncoCare Medical for $158M
  • 6/7/2022China Issues the Notice on Correction of Irregularities in Drug Procur...
  • 6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)
  • 6/6/2022Pfizer/CStone Cejemly Gets China Approval for Expanded Use in Advanced...
  • 6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...
  • 6/6/2022China Issues the 14th Five-Year National Health Plan with A New Focus ...
  • 6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification
  • 6/3/2022Patient Activeness During Online Medical Consultation in China: Multil...
  • Page:65/356 Total number of articles:10671: [First][<<] [63] [64] [65] [66] [67] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group